Likewise, addition of 2-O-desulfated heparin was able to reduce uptake, whereas 6-O-desulfated heparin or chondroitin sulfate (negative control) were significantly less effective at reducing uptake (Fig. 4a)
Chondroitin sulfate and 6-O-desulfated heparin incubation did not reduce the median fluorescence, verifying that 6-O-sulfation is also important for tau internalization ex vivo (Fig. 4d and Supplementary Fig. 3b)
Treatment of cells with an inhibitor for DNM2, Dynasore, was also able to reduce uptake of tau (Supplementary Fig. 2 f)
We found that internalization of tau can be efficiently competed by the presence of heparin or HS in the media (Fig. 4a)
Consistent with our previous results, incubation with heparin, heparan sulfate, or 2-O-desulfated heparin reduced uptake of tau as quantified by the median 488 fluorescence intensity (Fig. 4d)
In line with these observations a small molecule inhibitor of CDK4/6 that causes a stall in G1 phase (PD0332991) was sufficient to almost double the amount of tau taken up in H4 cells (Supplementary Fig. 2e)
Removal of N-sulfates or 2-O-sulfates had little effect on tau binding (15.0 ± 5 nM and 7.4 ± 1.0 nM, respectively), while removal of all O-sulfates and, in particular 6-O-sulfates, led to a significant decrease in tau binding (>1 μM in each case; Fig. 3c,d)
These results were consistent when tested in iPS-derived neurons (Fig. 4b), demonstrating that the 6-O-sulfation motif is indeed a critical determinant for cellular tau entry
Further, human iPS-derived neurons also showed a preference for smaller structures of tau, with fibrillized tau showing nearly no uptake (Fig. 1d)
Monomeric, oligomeric and sonicated fibrils were efficiently internalized, while fibril samples were not (Fig. 1c and Supplementary Fig. 1d)
Tau protein can form multiple quaternary structures in solution, and recent evidence suggests that small tau oligomeric species may play a critical role in the spread of tau pathology and neurotoxicity
These single gene knockdowns repressed uptake of tau monomer by over 50% (Fig. 2b) and also reduced the uptake of tau oligomers (Fig. 2c)
Endocytosis is known to increase during G1 phase25; therefore, it seemed logical that cell cycle regulators that can shorten the G1 phase could reduce the amount of tau uptake and vice versa.
The selective knockdown of genes such as TP53, led to a decrease in G1 length and thus an overall increase in cell proliferation (Supplementary Fig. 2d)
Further, these gene knockdowns were sufficient to reduce the uptake of tau in iPS-derived neurons (Fig. 2d)
Previous reports had indicated that internalization of tau could be regulated by HSPGs16, but our identification of HS6ST1, an enzyme that is responsible for 6-O-sulfation of HSPGs, supports a hypothesis that specific motifs on HSPGs might be important for tau uptake
Overexpression of these enzymes in H4 cells, showed a dramatic decrease in tau uptake with Sulf1 reducing uptake to 17 ± 9%, and Sulf2 reducing uptake to 36 ± 15% (Fig. 4e)
Overexpression of the constructs was confirmed with immunocytochemistry and qPCR analysis (Fig. 4f and Supplementary Fig. 3d) and the ability of the enzymes to reduce 6-O sulfation on the cell surface was confirmed by HPLC (Supplementary Fig. 3e,f)
BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.
If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.